ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NIH trial to add Trevena’s TRV027 for Covid-19 treatment
May 08, 2021TRV027 is an angiotensin II receptor type 1 (AT1 receptor) selective agonist and fights disruption within the renin-angiotensin-aldosterone system (RAAS) by attaching to and rebalancing AT1 receptor activation. -
TRV027 to be tested as COVID-19 illness treatment in clinical trial
June 17, 2020A clinical trial is set to investigate whether a molecule known as TRV027 is effective at preventing lung damage and the formation of blood clots in COVID-19 patients. -
Researchers to test potential COVID-19 treatment in UK
June 16, 2020Researchers are gearing up to evaluate whether a new drug can prevent lung damage and blood clots in people with COVID-19 in hospitals in the UK.
Pharma Sources Insight January 2025
